Literature DB >> 24034069

Mucous membrane pemphigoid.

Hong-Hui Xu1, Victoria P Werth, Ernesta Parisi, Thomas P Sollecito.   

Abstract

Mucous membrane pemphigoid (MMP) is chronic and frequently associated with exacerbations and remissions of clinical signs and symptoms. Clinicians should use pathologic and immunonologic techniques to help diagnose patients. Multidisciplinary collaboration is often necessary for the diagnosis and proper treatment of MMP. Systemic adjuvant immunosuppressive therapy is necessary for patients with progressive disease. In spite of the advances in available immunosuppressive medications and biologics, scarring is a significant complication in many cases. Surgical intervention is not curable; however, it may be necessary for restoring function and improving quality of life. Published by Elsevier Inc.

Entities:  

Keywords:  Cicatricial pemphigoid; Mucous membrane; Ocular; Oral; Subepithelial autoimmune disease

Mesh:

Substances:

Year:  2013        PMID: 24034069      PMCID: PMC3928007          DOI: 10.1016/j.cden.2013.07.003

Source DB:  PubMed          Journal:  Dent Clin North Am        ISSN: 0011-8532


  104 in total

1.  Mucosal morbidity in patients with epidermolysis bullosa acquisita.

Authors:  M C Luke; T N Darling; R Hsu; R M Summers; J A Smith; B I Solomon; G R Thomas; K B Yancey
Journal:  Arch Dermatol       Date:  1999-08

2.  Cicatricial pemphigoid successfully treated with pulse intravenous cyclophosphamide.

Authors:  A G Pandya; K J Warren; P R Bergstresser
Journal:  Arch Dermatol       Date:  1997-02

3.  Adhesion molecules and oral mucosal diseases.

Authors:  L R Eversole
Journal:  Oral Dis       Date:  1996-09       Impact factor: 3.511

4.  Limbal conjunctival Langerhans cell density in ocular cicatricial pemphigoid: an indirect immunofluorescence study on Dispase-split conjunctiva.

Authors:  B Bodaghi; V Bertin; M Paques; M Toublanc; C Dezutter-Dambuyant; T Hoang-Xuan
Journal:  Curr Eye Res       Date:  1997-08       Impact factor: 2.424

5.  Laminin-6 and laminin-5 are recognized by autoantibodies in a subset of cicatricial pemphigoid.

Authors:  L S Chan; A A Majmudar; H H Tran; F Meier; G Schaumburg-Lever; M Chen; G Anhalt; D T Woodley; M P Marinkovich
Journal:  J Invest Dermatol       Date:  1997-06       Impact factor: 8.551

6.  Ocular cicatricial pemphigoid antigen: partial sequence and biochemical characterization.

Authors:  S Tyagi; K Bhol; K Natarajan; C Livir-Rallatos; C S Foster; A R Ahmed
Journal:  Proc Natl Acad Sci U S A       Date:  1996-12-10       Impact factor: 11.205

7.  Combination therapy with nicotinamide and tetracyclines for cicatricial pemphigoid: further support for its efficacy.

Authors:  L Reiche; F Wojnarowska; E Mallon
Journal:  Clin Exp Dermatol       Date:  1998-11       Impact factor: 3.470

8.  Significantly increased occurrence of HLA-DQB1*0301 allele in patients with ocular cicatricial pemphigoid.

Authors:  L S Chan; C Hammerberg; K D Cooper
Journal:  J Invest Dermatol       Date:  1997-02       Impact factor: 8.551

9.  A retrospective study of the management of oral mucous membrane pemphigoid with dapsone.

Authors:  K N Ciarrocca; M S Greenberg
Journal:  Oral Surg Oral Med Oral Pathol Oral Radiol Endod       Date:  1999-08

10.  Mucous membrane pemphigoid: a dual circulating antibody response with IgG and IgA signifies a more severe and persistent disease.

Authors:  J Setterfield; P J Shirlaw; M Kerr-Muir; S Neill; B S Bhogal; P Morgan; K Tilling; S J Challacombe; M M Black
Journal:  Br J Dermatol       Date:  1998-04       Impact factor: 9.302

View more
  21 in total

Review 1.  Autoimmune Blistering Diseases in the Elderly: Clinical Presentations and Management.

Authors:  Minhee Kim; Luca Borradori; Dédée F Murrell
Journal:  Drugs Aging       Date:  2016-10       Impact factor: 3.923

Review 2.  Oral manifestations of systemic disease.

Authors:  S R Porter; V Mercadante; S Fedele
Journal:  Br Dent J       Date:  2017-11-10       Impact factor: 1.626

3.  Oral mucous membrane pemphigoid in a group of Thai patients-A 15-year retrospective study.

Authors:  Waranun Buajeeb; Kununya Pimolbutr; Naruemon Panpradit; Nis Okuma
Journal:  J Dent Sci       Date:  2021-11-24       Impact factor: 3.719

4.  Mucous membranepemphigoid in two half-sisters. The potential roles of autoantibodies to β4 integrin subunits and HLA-DQβ1*0301.

Authors:  Diogo Fabris Rabelo; Tegan Nguyen; Brooke Ann Caufield; Abdul Razzaque Ahmed
Journal:  J Dermatol Case Rep       Date:  2014-03-31

5.  Oral mucous membrane pemphigoid - Two case reports with varied clinical presentation.

Authors:  Sreedevi Dharman; Arvind Muthukrishnan
Journal:  J Indian Soc Periodontol       Date:  2016 Nov-Dec

6.  [A particular type of cicatricial Pemphigoid with unique IgA deposit].

Authors:  Amina Aounallah; Mariem Jrad; Mehdi Ksiaa; Sana Mokni; Wafa Saidi; Lobna Boussofara; Badreddine Sriha; Mohamed Denguezli; Najet Ghariani; Colandane Belajouza; Rafia Nouira
Journal:  Pan Afr Med J       Date:  2017-03-13

7.  Paraneoplastic mucous membrane pemphigoid with ocular and laryngeal involvement.

Authors:  Silvia Lambiel; Pavel Dulguerov; Emmanuel Laffitte; Igor Leuchter
Journal:  BMJ Case Rep       Date:  2017-08-11

8.  Ocular cicatricial pemphigoid.

Authors:  Cristina Stan; Emanuela Diaconu; Livia Hopirca; Nicoleta Petra; Anca Rednic; Cristina Stan
Journal:  Rom J Ophthalmol       Date:  2020 Apr-Jun

9.  Esophageal Cicatricial Pemphigoid as an Isolated Involvement Treated with Mycophenolate Mofetil.

Authors:  Sandra Sánchez Prudencio; Daniel Domingo Senra; Daniel Martín Rodríguez; Belén Botella Mateu; Carlos Esteban Jiménez-Zarza; Felipe de la Morena López; José Jiménez Reyes; Manuel Nevado Santos; Beatriz de Cuenca Morón
Journal:  Case Rep Gastrointest Med       Date:  2015-10-18

10.  Successful treatment of mucous membrane pemphigoid with bortezomib.

Authors:  Lina Saeed; Timothy H Schmidt; Lianne S Gensler; Andrew J Gross; Lindy P Fox; Tiffany C Scharschmidt; Karin Gaensler; Haley Naik; Michael A Rosenblum; Kanade Shinkai
Journal:  JAAD Case Rep       Date:  2017-12-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.